Real-world early outcomes of axicabtagene ciloleucel for relapsed or refractory (R/R) follicular lymphoma (FL).

被引：0
|
作者：
Jacobson, Caron Alyce
Hemmer, Michael T.
Hu, Zhen-Huan
Frank, Matthew Joshua
Popplewell, Leslie
Ahmed, Nausheen
Lin, Yi
Best, Timothy
Beygi, Sara
Miao, Harry H.
Fu, Christine
Sun, Fang
Xu, Hairong
Pasquini, Marcelo C.
机构：
[1] Dana Farber Canc Inst, Boston, MA USA
[2] Kite, Santa Monica, CA USA
[3] Stanford Univ, Stanford, CA USA
[4] City Hope Natl Med Ctr, Duarte, CA USA
[5] Univ Kansas, Med Ctr, Westwood, KS USA
[6] Mayo Clin, Rochester, MN USA
[7] Med Coll Wisconsin, CIBMTR, Dept Med, Milwaukee, WI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7509
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Treatment Patterns and Health/Economic Outcomes in Relapsed/Refractory Follicular Lymphoma: A Real-World Study
    van der Jagt, Richard
    Hamm, Caroline
    Fleury, Isabelle
    Lambert-Obry, Veronique
    Laliberte, Avril Gouault
    Castonguay, Alex
    Wagner, Dennis
    Toltl, Lisa
    Lachaine, Jean
    BLOOD, 2017, 130
  • [22] Matching-Adjusted Indirect Comparisons of Axicabtagene Ciloleucel to Mosunetuzumab for the Treatment of Relapsed/ Refractory Follicular Lymphoma
    Ray, Markqayne D.
    Kanters, Steve
    Beygi, Sara
    Best, Timothy
    Wulff, Jacob
    Limbrick-Oldfield, Eve
    Patel, Anik R.
    Oluwole, Olalekan O.
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (09): : 885e1 - 885e11
  • [23] Cost-Effectiveness of Axicabtagene Ciloleucel for Adult Patients with Relapsed or Refractory Follicular Lymphoma in the United States
    Oluwole, Olalekan O.
    Ray, Markqayne D.
    Rosettie, Katherine L.
    Ball, Graeme
    Jacob, Jorge
    Bilir, Pinar
    Patel, Anik R.
    Jacobson, Caron A.
    BLOOD, 2022, 140 : 10822 - 10824
  • [24] Cost-Effectiveness of Axicabtagene Ciloleucel for Adult Patients With Relapsed or Refractory Follicular Lymphoma in the United States
    Oluwole, Olalekan O.
    Ray, Markqayne D.
    Rosettie, Katherine L.
    Ball, Graeme
    Jacob, Jorge
    Bilir, S. Pinar
    Patel, Anik R.
    Jacobson, Caron A.
    VALUE IN HEALTH, 2024, 27 (08) : 1030 - 1038
  • [25] Primary Clinical Response of Relmacabtagene Autoleucel in Adults with Relapsed/Refractory Follicular Lymphoma (r/r FL) in China
    Song, Yuqin
    Ying, Zhitao
    Yang, Haiyan
    Guo, Ye
    Li, Wenyu
    Zou, Dehui
    Wu, Jianqiu
    Yang, Su
    Zhang, Pian
    Ma, Meilin
    Zhou, Zisong
    Zheng, Hongxia
    Zhu, Jun
    BLOOD, 2021, 138
  • [26] Real-world outcomes of axicabtagene ciloleucel in adult patients with primary mediastinal B-cell lymphoma
    Crombie, Jennifer L.
    Nastoupil, Loretta J.
    Redd, Robert
    Tang, Kevin
    Shouse, Geoffrey
    Herrera, Alex F.
    Chow, Victor A.
    Shadman, Mazyar
    Puglianini, Omar Castaneda
    Saucier, Anna
    Jacobson, Caron A.
    Armand, Philippe
    Simmons, Gary
    BLOOD ADVANCES, 2021, 5 (18) : 3563 - 3567
  • [27] Clinical Outcomes with Prophylactic Corticosteroid Use for Axicabtagene Ciloleucel (axicel) in Patients with Relapsed/Refractory Large B-Cell Lymphoma (R/ R LBCL): A Multicenter Analysis
    Vuyyala, Sowjanya
    Corraes, Andre De Menezes Silva
    Bailey, Megumi
    Iqbal, Madiha
    Munoz, Javier L.
    Hunter, Bradley
    Bansal, Radhika
    Patel, Krish
    Kharfan-Dabaja, Mohamed A.
    Rosenthal, Allison C.
    Wang, Yucai
    Paludo, Jonas
    Johnston, Patrick B.
    Bennani, N. Nora
    Villasboas, J. C. C.
    Durani, Urshila
    Ansell, Stephen M.
    Lin, Yi
    Khurana, Arushi
    BLOOD, 2023, 142
  • [28] Earlier Steroid Use with Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/Refractory Large B Cell Lymphoma (R/R LBCL)
    Topp, Max S.
    van Meerten, Tom
    Houot, Roch
    Minnema, Monique
    Milpied, Noel
    Lugtenburg, Pieternella J.
    Thieblemont, Catherine
    Wermke, Martin
    Song, Kevin
    Avivi, Irit
    Kuruvilla, John
    Duehrsen, Ulrich
    Chu, Rachel
    Zheng, Lianqing
    Plaks, Vicki
    Kerber, Anne
    Kersten, Marie Jose
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S101 - S101
  • [29] Results of R-ESHAP as salvage therapy in refractory/relapsed follicular lymphoma: a real-world experience on behalf of GELCAB group
    A. Muntañola
    T. Baumann
    A. C. Caballero
    B. Sánchez-González
    S. Mercadal
    L. Escoda
    A. Soler
    L. Iserte
    M. Canet
    M. T. Villalobos
    L. Magnano
    M. Sorigué
    O. García
    A. Salar
    A. López-Guillermo
    J. M. Sancho
    Annals of Hematology, 2020, 99 : 1627 - 1634
  • [30] Results of R-ESHAP as salvage therapy in refractory/relapsed follicular lymphoma: a real-world experience on behalf of GELCAB group
    Muntanola, A.
    Baumann, T.
    Caballero, A. C.
    Sanchez-Gonzalez, B.
    Mercadal, S.
    Escoda, L.
    Soler, A.
    Iserte, L.
    Canet, M.
    Villalobos, M. T.
    Magnano, L.
    Sorigue, M.
    Garcia, O.
    Salar, A.
    Lopez-Guillermo, A.
    Sancho, J. M.
    ANNALS OF HEMATOLOGY, 2020, 99 (07) : 1627 - 1634
12345